9-14 | Here is an update from MSF Emergency Operations Manager Karline Kleijer on the situation of the Rohingya in Rakhine State:
9-6 | Rohingya refugees fleeing to Bangladesh urgently require medical and humanitarian assistance, as an already dire humanitarian situation along the border with Myanmar worsens. By 6 September, over 146,000 people had crossed into Bangladesh, fleeing violence in Rakhine state, Myanmar. This figure, coming on top of 75,000 people who have arrived since violence began in October 2016, represents one of the largest influxes ever of Rohingyas into Bangladesh.
8-22 | Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the US pharmaceutical corporation Pfizer for its PCV13 product, marketed as Prevnar13. “It’s unfair and unacceptable that almost a million children die each year from pneumonia, even though a life-saving vaccine is available.
7-25 | Global attention needed to prevent and treat AIDS in antiretroviral era, with 50% of hospital admissions in MSF hospitals already on treatment and showing clinical signs of failure. An unacceptably high number of people continue to develop and die of AIDS1-related diseases across sub-Saharan Africa.
5-5 | Manila, Philippines is set to host the 18th round of the multilateral trade deal - the Regional Comprehensive Economic Partnership (RCEP) that encompasses 50% of the global population. With the Philippines holding the chairmanship of ASEAN for 2017, it can be an opportune time for Philippines to take the lead in ensuring that market gains will not trump the right of millions of people to access affordable medicines.